Detalhe da pesquisa
1.
Unlocking Preclinical Alzheimer's: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics.
Int J Mol Sci
; 25(9)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38731955
2.
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Mol Psychiatry
; 27(4): 1990-1999, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173266
3.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
Alzheimers Dement
; 19(6): 2317-2331, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464806
4.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
Alzheimers Dement
; 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698882
5.
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.
Mol Cell Proteomics
; 18(3): 546-560, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30606734
6.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
7.
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Alzheimers Dement
; 17(10): 1628-1640, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991015
8.
Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.
J Int Neuropsychol Soc
; 25(1): 39-47, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30369339
9.
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimers Dement
; 15(5): 644-654, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853464
10.
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
Alzheimers Dement
; 15(6): 742-753, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967340
11.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimers Dement
; 15(11): 1478-1488, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495601
12.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimers Dement
; 15(6): 817-827, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078433
13.
Cortical microstructural changes along the Alzheimer's disease continuum.
Alzheimers Dement
; 14(3): 340-351, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080407
14.
The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients.
Int J Mol Sci
; 19(8)2018 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126230
15.
Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.
J Stroke Cerebrovasc Dis
; 26(8): 1670-1677, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412318
16.
GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.
Alzheimers Res Ther
; 16(1): 44, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413990
17.
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Genome Med
; 15(1): 79, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794492
18.
Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data.
Rev Psiquiatr Salud Ment (Engl Ed)
; 15(3): 167-175, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272739
19.
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.
Front Aging Neurosci
; 14: 840651, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35386118
20.
Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
J Neurosci
; 30(19): 6667-77, 2010 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20463229